Loading…
Health Catalyst, Inc. is projected to rise to $3.10 by 2027, a +35% move from its current price of $2.29. HCAT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.20 | $2.29 | $2.38 | +0.02% |
| Jul 13 | $2.16 | $2.29 | $2.43 | +0.04% |
| Jul 14 | $2.14 | $2.29 | $2.46 | +0.06% |
| Jul 15 | $2.11 | $2.29 | $2.48 | +0.08% |
| Jul 16 | $2.09 | $2.29 | $2.51 | +0.10% |
| Jul 17 | $2.08 | $2.29 | $2.53 | +0.11% |
| Jul 18 | $2.06 | $2.29 | $2.55 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.06 | $2.29 | $2.55 | +0.13% |
| Week 2 | $1.97 | $2.30 | $2.67 | +0.27% |
| Week 3 | $1.91 | $2.30 | $2.77 | +0.40% |
| Week 4 | $1.86 | $2.30 | $2.85 | +0.54% |
| Week 5 | $1.82 | $2.31 | $2.93 | +0.67% |
| Week 6 | $1.78 | $2.31 | $3.00 | +0.81% |
| Week 7 | $1.74 | $2.31 | $3.07 | +0.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Health Catalyst, Inc. is a healthcare technology company that provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services.
It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
It was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017.
Health Catalyst, Inc. (HCAT) currently trades at $2.29, with a market cap of $169.22M and a rank of 3879. The stock’s near-term technical picture is mixed, with a neutral sentiment and a recent RSI reading of 80.
The stock’s current price action sits between a 30-day range of $1.71–$3.07, with a support level at $1.26 and a resistance level at $2.29. The forecast horizon shows a bullish long-term path, with annual avg prices rising from $2.29 in 2026 to higher levels through 2050 and corresponding positive ROIs, highlighting meaningful upside potential over time.
A major floor 56.5% below — a decisive break under it would weaken the trend.
The nearest floor, 41.9% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 27.9% above — clearing it would confirm fresh momentum.
Key HCAT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCAT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.26 | Buy | $2.23 | Buy |
| MA 10 | $2.13 | Buy | $2.13 | Buy |
| MA 20 | $1.94 | Buy | $1.98 | Buy |
| MA 50 | $1.64 | Buy | $1.75 | Buy |
| MA 100 | $1.53 | Buy | $1.75 | Buy |
| MA 200 | $2.06 | Buy | $2.19 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 72.26 | Sell |
| Stoch RSI (14) | 80.11 | Sell |
| CCI (20) | 121.79 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 30.11 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.38 | Buy |
| Awesome (5,34) | 0.50 | Buy |
| Ultimate (7,14,28) | 80.02 | Sell |
| Momentum (10) | 0.52 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 2.30 | Sell |
| ADX (14) | 29.76 | Buy |
| ATR (14) | 0.07 | Info |
Technical snapshot for the next 30 days shows a NEUTRAL sentiment, with RSI14 at 80, SMA50 at $1.57 and SMA200 at $2.07. The immediate trading range spans from $1.71 to $3.07, providing support at $1.26 and resistance at $2.29.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.996 | $2.29 | $3.18 | 0% | Neutral | |
| $2.35 | $3.10 | $4.37 | +35% | Bullish | |
| $2.70 | $3.71 | $5.51 | +62% | Bullish | |
| $2.93 | $4.17 | $6.43 | +82% | Bullish | |
| $2.83 | $4.17 | $6.65 | +82% | Bullish | |
| $2.72 | $4.12 | $6.77 | +80% | Bullish | |
| $2.83 | $4.42 | $7.44 | +93% | Bullish | |
| $3.35 | $5.37 | $9.26 | +135% | Bullish | |
| $4.24 | $6.98 | $12.27 | +205% | Bullish | |
| $4.14 | $6.99 | $12.54 | +205% | Bullish | |
| $5.77 | $10.95 | $21.29 | +378% | Bullish | |
| $7.24 | $16.09 | $35.04 | +602% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.996 | $2.29 | $2.87 | +0.00% |
| August 2026 | $1.99 | $2.38 | $2.94 | +3.84% |
| September 2026 | $1.93 | $2.33 | $2.93 | -2.00% |
| October 2026 | $2.01 | $2.45 | $3.12 | +5.01% |
| November 2026 | $2.07 | $2.54 | $3.28 | +3.90% |
| December 2026 | $1.97 | $2.44 | $3.18 | -4.02% |
Click any year to see its month-by-month HCAT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HCAT is projected to trade between $0.996 and $3.18, averaging $2.29 — a potential gain of 0% from today's $2.29. A consolidation phase looks the most probable path here.
Health Catalyst, Inc.'s 2027 outlook centres on $3.10, within a $2.35 to $4.37 range. That is up +35% on the projected 2026 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2028, HCAT could reach as high as $5.51, with a base case around $3.71 and support toward $2.70 — roughly +62% from $2.29. Buyers look set to stay in control over this stretch.
Expect HCAT to range from $2.93 to $6.43 through 2029. The $4.17 average target implies a +82% move from current prices. That is up +12% on the projected 2028 average. Momentum favours further upside here.
The HCAT price prediction for 2030 points to an average of $4.17 (low $2.83, high $6.65) — a potential gain of +82% on today's $2.29. Buyers look set to stay in control over this stretch.
In 2031, HCAT is projected to trade between $2.72 and $6.77, averaging $4.12 — a potential gain of +80% from today's $2.29. That is -1% versus the projected 2030 average. Momentum favours further upside here.
Health Catalyst, Inc.'s 2032 outlook centres on $4.42, within a $2.83 to $7.44 range. That is up +7% on the projected 2031 average. That marks a +93% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, HCAT could reach as high as $9.26, with a base case around $5.37 and support toward $3.35 — roughly +135% from $2.29. Momentum favours further upside here.
Expect HCAT to range from $4.24 to $12.27 through 2034. The $6.98 average target implies a +205% move from current prices. That is up +30% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The HCAT price prediction for 2035 points to an average of $6.99 (low $4.14, high $12.54) — a potential gain of +205% on today's $2.29. Momentum favours further upside here.
In 2040, HCAT is projected to trade between $5.77 and $21.29, averaging $10.95 — a potential gain of +378% from today's $2.29. That is up +57% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Health Catalyst, Inc.'s 2050 outlook centres on $16.09, within a $7.24 to $35.04 range. That is up +47% on the projected 2040 average. That marks a +602% change versus current levels. Momentum favours further upside here.
Investing $1,000 in HCAT today (≈ 436.681223 HCAT) could be worth
$7,024.04
+$6,024.04 (+602%) by 2050 · US Dollar
Based on the average projected HCAT price of $16.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCATwould be worth at today's price.
$1,000 invested in HCAT on Jul 10, 2025 (≈ 250.626566 HCAT) would be worth
$573.93
-$426.07 (-42.6%) today · 0.57× · US Dollar
Based on a HCAT entry price of $3.99 vs. today's $2.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.08 | $1,100.96 | +10.1% |
| 1 month ago | $1.6 | $1,431.25 | +43.1% |
| 3 months ago | $0.996 | $2,299.2 | +129.9% |
| 6 months ago | $2.46 | $930.89 | -6.9% |
| 1 year ago | $3.99 | $573.93 | -42.6% |
| All time (5.0y) ago | $57.9 | $39.55 | -96.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCAT forecast.
Our base-case forecast reaches $4.60 around 2033.
Implied market cap at $4.60: $339.91M
The multi-year forecast is bullish, with rising average prices and strong ROI headlines into 2030, 2040 and 2050. In 2027 the average price is projected at $3.14 (min $2.35, max $4.52) with a 37.2% ROI and a BULLISH sentiment; in 2028 the average is $3.77 (min $2.69, max $5.73) with a 64.7% ROI and a BULLISH sentiment; and in 2029 the average is $4.21 (min $2.88, max $6.67) with an 83.7% ROI and a BULLISH sentiment. By 2030 the average is $4.20 (min $2.77, max $6.91) with an 83.6% ROI and a BULLISH sentiment.
The forecast continues to be bullish through 2031–2035, then accelerates into 2040 with an average of $10.98, a max of $22.25, a min of $5.39 and a 379.5% ROI; and into 2050 with an average of $15.46, a max of $35.36, a min of $6.96 and a 575.3% ROI. While these are estimates and not guarantees, the pattern shows meaningful upside potential over the long term with bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast projects an average price of $4.20, with a min of $2.77 and a max of $6.91, an ROI of 83.6%, and a BULLISH sentiment.
Forecasts show a bullish sentiment from 2027 onward, with rising average prices (e.g., $3.14 in 2027, $3.77 in 2028, $4.21 in 2029) and increasing ROIs (up to 83.7% in 2029 and higher thereafter), though 2026 is neutral with an average of $2.29.
Yes. The forecast max price reaches $6.91 in 2030 and rises further with a max of $22.25 in 2040 and $35.36 in 2050.
The current price is $2.29 and the market cap is $169.22M.
The near-term picture is NEUTRAL, with RSI14 at 80, 30-day range from $1.71 to $3.07, and support at $1.26 with resistance at $2.29.
Health Catalyst, Inc. Community Discussion
0Share your Health Catalyst, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.